Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer

The aim of this study was to address one of the major challenges of the actual era of nanomedicine namely, the bioavailability of poorly water soluble drugs such as Silymarin. We developed new, biodegradable, and biocompatible nanosized shuttles for Silymarin targeted delivery in colon-cancer cells....

Descripción completa

Detalles Bibliográficos
Autores principales: Radu, Ionut-Cristian, Hudita, Ariana, Zaharia, Catalin, Stanescu, Paul O., Vasile, Eugenia, Iovu, Horia, Stan, Miriana, Ginghina, Octav, Galateanu, Bianca, Costache, Marieta, Langguth, Peter, Tsatsakis, Aristidis, Velonia, Kelly, Negrei, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539237/
https://www.ncbi.nlm.nih.gov/pubmed/28824432
http://dx.doi.org/10.3389/fphar.2017.00508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539237/
https://www.ncbi.nlm.nih.gov/pubmed/28824432
http://dx.doi.org/10.3389/fphar.2017.00508

Ejemplares similares